Adrenal cortex cancer is a rare cancer that starts in the outer layer of the adrenal gland. People with adrenal cortex cancer may notice abdominal pain, a feeling of fullness, weight changes, or symptoms from excess hormones like facial hair growth, acne, high blood pressure, or muscle weakness. It can occur at any age, but most cases are found in adults, and some are found in children. Adrenal cortex cancer can be aggressive, and outlook depends on stage and response to treatment. Treatment often includes surgery to remove the tumor, with medicines like mitotane and sometimes chemotherapy or radiation to help control the disease.
Overview
Adrenal cortex cancerSymptoms
Adrenal cortex cancer may cause belly pain or fullness, a lump, unintentional weight change, and fatigue. Hormone effects can bring high blood pressure, easy bruising or stretch marks, menstrual or sexual changes, and early symptoms such as new facial hair.
Outlook and prognosis
Many people with adrenal cortex cancer do well when it’s found early and removed, sometimes with medicines to lower hormone effects. If it’s advanced, targeted drugs and radiation can help control growth and symptoms. Regular scans and hormone checks guide next steps.
Causes and risk factors
Adrenal cortex cancer usually arises sporadically; the exact cause is unknown. Risk factors for adrenal cortex cancer include certain inherited syndromes (Li‑Fraumeni, Lynch, Beckwith‑Wiedemann, MEN1), childhood onset, and female sex. Lifestyle or environmental links remain unclear; most cases aren’t inherited.
Genetic influences
Genetics play a meaningful role in adrenal cortex cancer. Some cases arise from inherited syndromes, while many involve acquired DNA changes in the tumor. Family history, especially with early symptoms of adrenal cortex cancer or multiple cancers, may warrant genetic counseling and testing.
Diagnosis
Doctors diagnose adrenal cortex cancer using blood and urine hormone tests plus imaging such as CT or MRI. A biopsy or surgical removal with pathology confirms the diagnosis and helps stage disease.
Treatment and drugs
Adrenal cortex cancer is treated with surgery to remove the tumor when possible, often followed by the drug mitotane and, in some cases, chemotherapy. Some people also receive targeted or immunotherapy in specialized centers. Ongoing hormone management helps control symptoms and wellbeing.
Symptoms
Many people first notice body changes that don’t seem connected—blood pressure creeping up, unusual weight gain around the middle, or new hair growth. Early symptoms of adrenal cortex cancer can be easy to miss, because many come from hormone shifts rather than a visible lump. Symptoms vary from person to person and can change over time.
Extra cortisol can cause weight to collect around the belly and upper back. You might notice a rounder face and thinner arms or legs.
Climbing stairs or rising from a chair can start to feel harder. This comes from muscle loss driven by hormone changes.
Numbers may climb despite healthy eating and regular activity. In adrenal cortex cancer, hormones like aldosterone or cortisol can push pressure up.
Cortisol can raise blood sugar, leading to thirst, frequent urination, or more fatigue. Some people are told they have new or worsening diabetes.
How people usually first notice Adrenal cortex cancer?
Many people first notice adrenal cortex cancer because of hormone-related changes that don’t match the rest of their health story, like sudden weight gain in the face and trunk with thin arms and legs, new or worsening high blood pressure, easy bruising, or new acne and facial hair growth in women. Others are alerted by signs of excess androgens or cortisol in children, such as rapid growth, early puberty changes, or a deepening voice, or by symptoms like unexplained muscle weakness and persistent fatigue. Sometimes the first signs are less specific—abdominal fullness, pain in the back or side, or a lump felt during a routine exam or on imaging done for another reason—which then leads doctors to check adrenal hormones and perform scans.
Types of Adrenal cortex cancer
Adrenal cortex cancer can look different from person to person, largely based on which hormones the tumor makes and how fast it grows. Clinicians often describe them in these categories: hormone-secreting (functional) versus non‑secreting (nonfunctional), and by stage from localized to metastatic. People may notice different sets of symptoms depending on their situation. Understanding the main types of adrenal cortex cancer helps explain why symptoms range from subtle to very noticeable changes in weight, blood pressure, and body hair patterns.
Functional tumors
These tumors produce extra hormones, which can drive symptoms like rapid weight gain, muscle weakness, high blood pressure, or menstrual and sexual changes. Symptoms often reflect the specific hormone made, such as cortisol, aldosterone, or androgens. Early symptoms of adrenal cortex cancer in this group may be mistaken for common issues like stress or high blood pressure.
Nonfunctional tumors
These do not make excess hormones, so symptoms may be minimal at first. Many are found incidentally on imaging or cause symptoms later from pressure or size, such as abdominal fullness or pain. Because hormone signs are absent, diagnosis can be delayed compared with functional tumors.
Cortisol-secreting
Excess cortisol can lead to Cushing-like features, including easy bruising, rounder face, high blood sugar, and muscle thinning. People may also have mood changes, fatigue, and weak bones over time. Swelling in the neck or trunk can be more noticeable than in the arms and legs.
Aldosterone-secreting
Too much aldosterone can cause resistant high blood pressure and low potassium. People might notice muscle cramps, tingling, or frequent urination. Some experience headaches or palpitations when potassium is very low.
Androgen-secreting
Extra androgens can cause oily skin, acne, and increased body or facial hair. Women may notice irregular periods, scalp hair thinning, or a deeper voice. In children, early puberty signs can appear sooner than expected.
Estrogen-secreting
Excess estrogen can cause breast tenderness or enlargement and, in women, irregular uterine bleeding. Men may notice breast enlargement and reduced libido. These hormone effects may be the earliest clue to the tumor type.
Localized disease
When confined to the adrenal gland, symptoms mainly reflect hormone excess if present, or a feeling of fullness from the mass. Some people have few symptoms aside from abnormal lab tests. Imaging often finds a mass before widespread effects develop.
Locally advanced
Tumors that extend into nearby tissues or veins can cause persistent abdominal or back pain and earlier satiety. Hormone-related symptoms may intensify as tumor size increases. Fatigue and unintentional weight loss can start to appear.
Metastatic disease
When cancer spreads to distant organs, symptoms can include significant weight loss, pain where it has spread, and worsening fatigue. Hormone excess may continue or fluctuate, adding blood pressure swings or blood sugar changes. The balance of symptoms can shift over time.
What genetics can tell you about symptoms
Some genetic changes, like TP53 mutations in Li-Fraumeni syndrome, raise the chance of adrenal cortex cancer and often lead to tumors at younger ages. Tumors linked to these variants may produce excess hormones, causing symptoms like rapid weight gain, high blood pressure, or facial hair growth.
Causes and risk factors
Most cases of adrenal cortex cancer happen without a clear cause.
Risk is higher in young children and in adults in their 40s to 50s, and it is slightly more common in women.
A small share are linked to rare inherited syndromes passed through families.
There are few proven environmental or lifestyle risk factors for adrenal cortex cancer, and consistent links are still lacking.
Having risk factors doesn’t mean you’ll definitely develop the condition.
Environmental and biological risk factors
Understanding what may raise the chance of adrenal cortex cancer (also called adrenocortical carcinoma) can guide when to seek evaluation. Researchers are still exploring how outside influences interact with our inner biology. Below are biological patterns and environmental considerations linked to risk, based on what is known today. These do not predict who will be affected, but they can help frame conversations about risk factors for adrenal cortex cancer.
This cancer occurs more often in very young children and in adults in midlife. Risk is relatively higher under age 5 and again around ages 40–50, compared with other ages. Clinicians may be more alert to adrenal symptoms in these groups.
People assigned female at birth are affected slightly more often than those assigned male at birth. The reason for this difference is not fully understood. It may relate to hormonal biology of the adrenal cortex.
No specific environmental exposure has been consistently tied to adrenal cortex cancer. Studies have examined radiation and certain industrial chemicals, but evidence remains limited. More research is needed before naming clear environmental risk factors.
Genetic risk factors
Several inherited conditions raise the chance of adrenal cortex cancer, especially in children, while many cases still occur without a known family syndrome. Carrying a genetic change doesn’t guarantee the condition will appear. If you or your child has one of these syndromes, knowing early symptoms of adrenal cortex cancer and asking about genetics-guided checkups can support earlier care. In some regions, a single inherited TP53 change is more common, which can cluster cases in local families.
Li-Fraumeni syndrome: An inherited change in the TP53 gene can strongly raise the risk of adrenal cortex cancer, particularly in children. In parts of southern Brazil, a common TP53 change has been linked to higher family rates.
Beckwith-Wiedemann syndrome: Changes in growth-control genes on chromosome 11 increase childhood risk of adrenal cortex cancer. The risk is highest in early childhood and tends to fall with age.
Lynch syndrome: Inherited changes in DNA repair genes raise the chance of several cancers, and a small number of families also show adrenal cortex cancer. Overall risk remains low but is higher than in the general population.
MEN1 syndrome: Changes in the MEN1 gene can cause growths in hormone-making glands, including the adrenal cortex. Most adrenal tumors here are benign, but cancer can occur rarely.
Familial adenomatous polyposis: This APC-related condition mainly affects the colon, but adrenal tumors are more common in affected families. Adrenal cortex cancer is uncommon, yet reported more often than in those without this syndrome.
Carney complex: Inherited changes in PRKAR1A can lead to unusual adrenal growth and hormone issues. Cancer of the adrenal cortex is rare in this condition but has been described.
Family history: Having a close relative with adrenal cortex cancer may point to an inherited risk, even when no single syndrome is identified. A genetics evaluation can look for shared changes that run in families.
Acquired DNA changes: Most adrenal cortex cancers arise from genetic changes that develop only in the tumor and are not inherited. These changes affect cell growth pathways and drive uncontrolled growth.
Lifestyle risk factors
Evidence for lifestyle risk factors for adrenal cortex cancer is sparse. Most cases are not clearly linked to diet, exercise, or personal habits. Still, when people ask about lifestyle risk factors for adrenal cortex cancer, it helps to know what is and isn’t supported by research.
No proven link to higher adrenal cortex cancer incidence. Smoking does raise surgical and anesthesia risks if cancer occurs.
A direct association with adrenal cortex cancer is unproven. Obesity and low activity increase systemic inflammation and overall cancer risk, but data for this cancer are limited.
Diets high in processed meats and low in fruits and vegetables raise risk for several cancers. A specific connection to adrenal cortex cancer has not been demonstrated.
No clear relationship with adrenal cortex cancer risk. Alcohol raises risks for other cancers and can complicate treatment if adrenal cancer develops.
Risk prevention
Adrenal cortex cancer is rare, and there isn’t a single proven way to prevent it, but you can lower risks and catch problems earlier. Prevention is about lowering risk, not eliminating it completely. For most people, the biggest step is knowing family history and paying attention to new, unexplained hormone-related changes. If your family has a known inherited risk, tailored screening can help spot early symptoms of adrenal cortex cancer sooner, when treatment is more effective.
Ask relatives about any adrenal tumors or inherited cancer syndromes. Share this information with your doctor so your care can be tailored.
If adrenal tumors, childhood cancers, or Li-Fraumeni or Beckwith-Wiedemann run in your family, consider genetic counseling and testing. Results can guide screening plans for you and close relatives.
People with inherited risk may need regular hormone blood or urine tests and periodic imaging. MRI or ultrasound is often preferred to limit radiation exposure.
If you have Li‑Fraumeni syndrome, avoid unnecessary CT scans and X‑rays. Ask about MRI or ultrasound alternatives when appropriate.
Transmission
Adrenal cortex cancer is not contagious; it cannot be transferred between people through touch, coughing, sex, or everyday sharing at home or work. Most cases do not run in families, but a small number occur in people with inherited cancer‑risk syndromes such as Li‑Fraumeni or Beckwith‑Wiedemann.
In those families, how Adrenal cortex cancer is inherited is usually “dominant,” meaning a parent with the gene change has a 1 in 2 (50%) chance of passing it to each child. Sometimes the gene change happens for the first time in a child, so there may be no earlier family history.
When to test your genes
Consider genetic testing if you were diagnosed with adrenal cortex cancer at a young age, have bilateral or multiple endocrine tumors, or there’s a family history of adrenal, breast, brain, or sarcoma cancers. Testing is also reasonable for advanced or recurrent disease to guide targeted therapy. Ask a genetics professional first.
Diagnosis
People with adrenal cortex cancer may first notice changes like unexplained weight gain, new acne, or rising blood pressure, or a scan done for another reason finds a lump above a kidney. Doctors usually begin with questions about symptoms and a hands-on exam, then order tests to learn whether the adrenal gland is making excess hormones. For many, the diagnosis of adrenal cortex cancer moves step by step, from blood and urine tests to detailed imaging, and finally confirmation after surgery.
Your provider asks about symptoms such as weight changes, fatigue, hair growth, or menstrual shifts and checks blood pressure and body changes. Findings can point toward hormone overproduction or a mass in the adrenal area.
Blood tests look for excess cortisol, androgens, or aldosterone and measure related regulators like renin or ACTH. Abnormal hormone patterns raise concern that the adrenal mass is active and guide next tests.
Urine collections can measure hormone levels such as cortisol and metanephrines. These help confirm hormone excess and rule out a pheochromocytoma before any invasive procedure.
A low-dose dexamethasone suppression test checks whether cortisol production can be turned down. Lack of suppression suggests autonomous cortisol production by an adrenal tumor.
Stages of Adrenal cortex cancer
Staging describes how far adrenal cortex cancer has grown and where it has spread, which helps guide treatment and outlook. Different tests may be suggested to help determine the exact stage, including scans and hormone checks, and sometimes the final stage is confirmed after surgery. Sizes are often described in centimeters and inches so results are easier to picture.
Stage I
Localized: The tumor is small (5 cm or about 2 in or less) and limited to the adrenal gland. It hasn’t reached lymph nodes or nearby organs. Early symptoms of adrenal cortex cancer can be subtle, like new high blood pressure or unexpected weight changes.
Stage II
Larger localized: The tumor is bigger than 5 cm (about 2 in) but still confined to the adrenal gland. There’s no spread to lymph nodes or other organs. Some people notice signs of hormone overproduction, such as facial swelling or increased hair growth.
Stage III
Regional spread: The cancer has grown into nearby tissues, major veins, or regional lymph nodes. It is still within the region around the adrenal but no distant organs are involved. Scans may show the tumor touching or invading nearby structures.
Stage IV
Distant spread: The cancer has spread to distant organs, most often the liver, lungs, or bones. Care typically combines treatments to slow the cancer with support for symptoms and hormone balance. Clinical trials may also be discussed at this stage.
Outlook and prognosis
Looking ahead can feel daunting, but many people want straight talk about what adrenal cortex cancer may mean over time. The outlook depends on stage at diagnosis, tumor grade, whether surgery can fully remove the tumor, and how well it responds to treatments like medications that block adrenal hormones. Doctors call this the prognosis—a medical word for likely outcomes. When the cancer is caught early and completely removed, long-term survival is possible, and some people live many years cancer‑free. If it’s spread beyond the adrenal gland, treatment shifts toward control—shrinking or slowing the cancer, easing hormone‑related symptoms, and extending life.
Everyone’s journey looks a little different. Early symptoms of adrenal cortex cancer, such as unexplained weight gain, new high blood pressure, or changes in body hair from excess hormones, can lead to earlier detection and better odds if checked promptly. For advanced disease, survival is more limited, but newer combinations of surgery, targeted drugs, and immunotherapy can help some people live longer and feel better. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Rare inherited syndromes can raise risk, and genetic testing can sometimes provide more insight into prognosis.
With ongoing care, many people maintain a good quality of life—managing fatigue, blood pressure, and hormone swings so daily routines stay workable. Mortality varies widely by stage: localized tumors that are fully removed have the most favorable outcomes, while metastatic adrenal cortex cancer carries a higher risk and shorter average survival. Regular follow‑up scans and hormone checks matter because recurrence can happen, sometimes years later, and catching changes early opens more options. Talk with your doctor about what your personal outlook might look like.
Long-term effects
For many living with adrenal cortex cancer, the long view centers on hormone balance, risk of return, and effects of treatment. Long-term effects vary widely, and depend on tumor stage, hormone production, and the treatments used. Many remember that early symptoms of adrenal cortex cancer were subtle, while later changes can be more about ongoing fatigue, blood pressure, and metabolic health. Doctors often continue follow-up for years to watch hormones and scan for recurrence.
Some people have lasting effects from past high cortisol, aldosterone, or sex hormones. Blood pressure, blood sugar, weight, or body hair patterns may take time to settle.
After surgery or mitotane, the body may not make enough cortisol. Daily steroid tablets and stress dosing during illness can be lifelong.
Adrenal cortex cancer can come back in the adrenal area or elsewhere. Regular scans and blood or urine hormone tests are common for years.
If cancer spreads to the lungs, liver, or bones, long-term symptoms can include pain, shortness of breath, or fractures. Treatment focuses on control and comfort over time.
How is it to live with Adrenal cortex cancer?
Living with adrenal cortex cancer often means juggling fatigue, appetite or weight changes, and the side effects of surgery, chemotherapy, or hormone-blocking medicines, while also attending frequent scans and lab checks. Because these tumors can make extra hormones, some people face swings in blood pressure, blood sugar, mood, or muscle strength that can feel unpredictable until treatment steadies them. Daily life usually improves when a care team fine-tunes hormone replacement and symptom control, and when family or friends learn what signs—like sudden weakness, salt craving, or dizziness—mean it’s time to slow down or seek help. For many, clear routines, an emergency plan for adrenal crises, and honest communication at home and work reduce strain on everyone and make space for normal moments.
Treatment and drugs
Treatment for adrenal cortex cancer usually involves surgery to remove the tumor and, when possible, the entire affected adrenal gland. If the cancer has spread or surgery can’t remove it all, doctors may use medicines like mitotane, which targets adrenal cancer cells, and may add chemotherapy or radiation to shrink or control remaining disease. A doctor may adjust your dose to balance benefits and side effects, since these treatments can affect hormones and energy levels. Alongside medical treatment, lifestyle choices play a role, including managing blood pressure, blood sugar, and stress, and keeping up with follow-up scans and hormone tests. Although living with adrenal cortex cancer can feel overwhelming, supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Alongside medicines, non-drug therapies can help manage adrenal cortex cancer and its day-to-day impact. These approaches focus on removing or controlling tumors, easing symptoms, and supporting strength and wellbeing. Your team will tailor choices to the tumor’s spread, hormone effects, and your goals. Not every approach works the same way for everyone, so plans often mix several options.
An experienced surgeon may remove the adrenal tumor to lower hormone excess and relieve pressure-related symptoms. In some cases, surgery for limited spread can also reduce tumor burden.
Focused radiation can treat the tumor area or painful spots, especially in bone. It may help control growth and ease symptoms like pain.
Image-guided procedures can destroy small tumors with heat or cold, or cut off their blood supply. These are options when surgery isn’t possible and may be done as day procedures.
A tailored activity plan can rebuild strength, ease fatigue, and support balance. Therapists adjust exercises if hormone changes have weakened muscles.
Your genes may have an impact on how drugs work for you
Medicines for adrenal cortex cancer can work differently based on your genes, which affect how your liver enzymes process drugs and how cancer cells respond. Genetic testing may guide dose choices or drug selection, helping treatment be safer and more effective.
Pharmacological treatments
Treatment for adrenal cortex cancer focuses on shrinking or slowing the tumor and controlling excess hormones that cause day-to-day symptoms like high blood pressure, weight gain, or hair changes. Mitotane is the backbone drug for many, often paired with chemotherapy in advanced disease. Immunotherapy may help in some cases when chemotherapy isn’t effective or suitable. Not everyone responds to the same medication in the same way.
This adrenolytic drug targets adrenal tumor cells and lowers cortisol production. Many people need steroid replacement (for example, hydrocortisone) because mitotane can suppress healthy adrenal function. Dosing may be increased or lowered gradually to balance benefit and side effects.
The combination of etoposide, doxorubicin, and cisplatin plus mitotane is a common first-line regimen for advanced disease. First-line medications are those doctors usually try first, based on the best available evidence for benefit. It requires careful monitoring for nausea, fatigue, low blood counts, and kidney or heart effects.
Drugs such as pembrolizumab or nivolumab (sometimes with ipilimumab) may be used after chemotherapy or if chemotherapy is not an option. They help the immune system recognize and attack cancer, but can cause immune-related side effects that sometimes require steroids. Response rates vary, and close follow-up is essential.
Metyrapone, ketoconazole, osilodrostat, or mifepristone can control steroid excess and improve blood pressure, glucose, sleep, and energy. These medicines can ease early symptoms of adrenal cortex cancer like rapid weight gain, high blood pressure, and mood changes caused by high cortisol. Drugs that target symptoms directly are called symptomatic treatments.
Genetic influences
Most cases arise by chance, but in some families a change in a single gene raises the odds of developing adrenal cortex cancer (also called adrenocortical carcinoma). Family history is one of the strongest clues to a genetic influence. Inherited conditions such as Li-Fraumeni syndrome or Beckwith‑Wiedemann syndrome can raise risk, especially in children, because the genes involved act like safety checks for cell growth. Even with a known gene change, many people never develop this cancer, and the degree of risk can vary widely from one family to another. Genetic counseling and genetic testing for adrenal cortex cancer are often discussed when someone is diagnosed at a young age or when several relatives have related cancers, because results can guide screening and care for you and your family. If a hereditary cause is found, relatives may be offered testing and tailored checkups to spot problems early.
Is Adrenal cortex cancer genetic?
Genetics play a meaningful role in adrenal cortex cancer. Some cases arise from inherited syndromes, while many involve acquired DNA changes in the tumor. Family history, especially with early symptoms of adrenal cortex cancer or multiple cancers, may warrant genetic counseling and testing.
Pharmacogenetics—how genetics influence drug effects
Treatment plans for adrenal cortex cancer often include mitotane along with other medicines, and people don’t all respond the same. Genes can influence how quickly you process mitotane or chemotherapy drugs, which can affect the dose you need and the chance of side effects. Because mitotane levels vary widely between people, teams often check blood levels and adjust dosing; strong drug interactions are common because mitotane speeds up liver enzymes that clear many medicines, including steroid replacements. Testing the tumor’s DNA can also guide care: markers like mismatch repair deficiency or a very high number of mutations can make immunotherapy more likely to help. Inherited changes that raise the chance of adrenal cortex cancer may not choose the drug on their own, but they matter for care planning, family screening, and clinical trial options. If treatment hasn’t worked as expected or side effects have been hard to manage, talk with your care team about whether pharmacogenetic testing and drug level checks could personalize your regimen for adrenal cortex cancer.
Interactions with other conditions
Living with adrenal cortex cancer often means managing how hormone changes affect other health issues day to day. A condition may “exacerbate” (make worse) symptoms of another, so cortisol excess can drive high blood pressure, high blood sugar or diabetes, weight gain, bone loss, and mood changes, while androgen or estrogen excess can cause menstrual changes, fertility problems, or body-hair and skin shifts. Because these concerns are common, early symptoms of adrenal cortex cancer can be mistaken for more familiar problems like menopause, polycystic ovary syndrome, or stress-related weight changes, which can delay diagnosis. Treatment can interact with other diseases too: surgery or medicines like mitotane may lead to low cortisol, making infections or other illnesses hit harder, and they can change how certain drugs work, including blood thinners, seizure medicines, and birth control. Some people have inherited conditions such as Li-Fraumeni syndrome or Beckwith–Wiedemann syndrome, which raise the chance of adrenal cortex cancer alongside other cancers, so coordinated screening plans are important for the whole picture. Talk with your doctor about how your conditions may influence each other and whether any medications should be adjusted during treatment and recovery.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden weight loss, deep fatigue, and unusual skin darkening that didn’t match sun exposure. Families and communities once noticed patterns of severe stomach pain and weakness that progressed quickly, with doctors later finding a large mass high in the abdomen. Looking back helps explain why adrenal cortex cancer was once confused with other illnesses, especially when hormone changes drove symptoms that seemed unrelated, like facial swelling, rapid hair growth, or high blood pressure at a young age.
First described in the medical literature as a rare, aggressive tumor of the adrenal gland’s outer layer, early reports focused on what could be felt or seen during an exam or surgery. Before reliable imaging, many cancers were discovered only when they grew large enough to be noticed as a firm lump under the ribs or during operations done for something else. Autopsy studies in the early to mid-20th century added to the picture, showing that some tumors produced high levels of hormones such as cortisol, aldosterone, or androgens, which explained the striking mix of symptoms.
As medical science evolved, pathologists learned to distinguish adrenal cortex cancer from noncancerous growths under the microscope. The introduction of CT scans and MRI in the late 20th century changed everyday practice, allowing doctors to spot smaller adrenal tumors and to see which ones looked more suspicious. At the same time, blood and urine hormone testing became routine, helping clinicians connect early symptoms of adrenal cortex cancer—like easy bruising, muscle weakness, or resistant high blood pressure—to excessive hormone production.
In recent decades, knowledge has built on a long tradition of observation. Surgeons refined techniques to remove adrenal tumors more safely, and teams began using a combination of surgery and medicines like mitotane, along with selected chemotherapy, to lower the chance of the cancer returning. Cancer registries in the US and Europe showed that while adrenal cortex cancer remains uncommon, outcomes improve when care is concentrated in experienced centers and when hormone effects are treated alongside the tumor itself.
Advances in genetics revealed that a small proportion of people inherit a higher chance of developing adrenal cortex cancer, sometimes as part of conditions like Li-Fraumeni syndrome or Beckwith–Wiedemann syndrome. These findings explained why some children and certain families faced the diagnosis more often and led to careful screening in those at higher risk. Molecular studies also uncovered changes within tumor cells that may guide future treatments.
Over time, descriptions became more precise, separating adrenal cortex cancer from functional benign adenomas and from cancers that spread to the adrenal gland from other organs. Today’s understanding blends careful symptom history, hormone testing, modern imaging, and expert pathology—a far cry from the era when the disease was recognized only after it had grown large. Despite evolving definitions, the central goal has stayed the same: find adrenal cortex cancer earlier, treat it effectively, and manage hormone effects to help people maintain daily life.